Clostridium difficile: a problem of concern in developed countries and still a mystery in Latin America
Open Access
- 1 February 2012
- journal article
- review article
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 61 (2), 169-179
- https://doi.org/10.1099/jmm.0.037077-0
Abstract
Clostridium difficile-associated disease (CDAD) is caused by a spore-forming bacterium and can result in highly variable disease, ranging from mild diarrhoea to severe clinical manifestations. Infections are most commonly seen in hospital settings and are often associated with on-going antibiotic therapy. Incidences of CDAD have shown a sustained increase worldwide over the last ten years and a hypervirulent C. difficile strain, PCR ribotype 027/REA type BI/North American pulsed-field (NAP) type 1 (027/BI/NAP-1), has caused outbreaks in North America and Europe. In contrast, only a few reports of cases in Latin America have been published and the hypervirulent strain 027/BI/NAP-1 has, so far, only been reported in Costa Rica. The potential worldwide spread of this infection calls for epidemiological studies to characterize currently circulating strains and also highlights the need for increased awareness and vigilance among healthcare professionals in currently unaffected areas, such as Latin America. This review attempts to summarize reports of C. difficile infection worldwide, especially in Latin America, and aims to provide an introduction to the problems associated with this pathogen for those countries that might face outbreaks of epidemic strains of C. difficile for the first time in the near future.Keywords
This publication has 58 references indexed in Scilit:
- New types of toxin A-negative, toxin B-positive strains among clinical isolates of Clostridium difficile in AustraliaJournal of Medical Microbiology, 2011
- Immunomodulatory activities of surface-layer proteins obtained from epidemic and hypervirulent Clostridium difficile strainsJournal of Medical Microbiology, 2011
- The Changing Epidemiology of Clostridium difficile InfectionsClinical Microbiology Reviews, 2010
- Emergence of Clostridium difficile NAP1 in Latin AmericaJournal of Clinical Microbiology, 2010
- Infection Control Practices in Assisted Living CommunitiesGeriatric Nursing, 2009
- Clostridium difficile Infection in the Intensive Care UnitJournal of Intensive Care Medicine, 2009
- Toxin B is essential for virulence of Clostridium difficileNature, 2009
- The First Case of Antibiotic-associated Colitis by Clostridium difficile PCR Ribotype 027 in KoreaJournal of Korean Medical Science, 2009
- An outbreak of Clostridium difficile-associated disease (CDAD) in a German university hospitalEuropean Journal of Clinical Microbiology & Infectious Diseases, 2008
- Binary Toxin Production in Clostridium difficile Is Regulated by CdtR, a LytTR Family Response RegulatorJournal of Bacteriology, 2007